Betta Pharmaceuticals (China) Price Prediction
| 300558 Stock | 52.69 1.11 2.06% |
Oversold Vs Overbought
57
Oversold | Overbought |
Quarterly Earnings Growth 0.219 | EPS Estimate Next Quarter 0.19 | EPS Estimate Current Year 1.01 | EPS Estimate Next Year 1.34 | Wall Street Target Price 50.7 |
Using Betta Pharmaceuticals hype-based prediction, you can estimate the value of Betta Pharmaceuticals Co from the perspective of Betta Pharmaceuticals response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Betta Pharmaceuticals to buy its stock at a price that has no basis in reality. In that case, they are not buying Betta because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Betta Pharmaceuticals after-hype prediction price | CNY 53.11 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Betta |
Betta Pharmaceuticals After-Hype Price Prediction Density Analysis
As far as predicting the price of Betta Pharmaceuticals at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Betta Pharmaceuticals or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Betta Pharmaceuticals, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Betta Pharmaceuticals Estimiated After-Hype Price Volatility
In the context of predicting Betta Pharmaceuticals' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Betta Pharmaceuticals' historical news coverage. Betta Pharmaceuticals' after-hype downside and upside margins for the prediction period are 48.49 and 57.73, respectively. We have considered Betta Pharmaceuticals' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Betta Pharmaceuticals is not too volatile at this time. Analysis and calculation of next after-hype price of Betta Pharmaceuticals is based on 3 months time horizon.
Betta Pharmaceuticals Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Betta Pharmaceuticals is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Betta Pharmaceuticals backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Betta Pharmaceuticals, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.82 | 4.62 | 0.42 | 0.38 | 2 Events / Month | 1 Events / Month | In a few days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
52.69 | 53.11 | 0.80 |
|
Betta Pharmaceuticals Hype Timeline
Betta Pharmaceuticals is presently traded for 52.69on Shenzhen Stock Exchange of China. The entity has historical hype elasticity of 0.42, and average elasticity to hype of competition of 0.38. Betta is forecasted to increase in value after the next headline, with the price projected to jump to 53.11 or above. The average volatility of media hype impact on the company the price is over 100%. The price jump on the next news is forecasted to be 0.8%, whereas the daily expected return is presently at 0.82%. The volatility of related hype on Betta Pharmaceuticals is about 998.15%, with the expected price after the next announcement by competition of 53.07. The company reported the revenue of 2.46 B. Net Income was 348.03 M with profit before overhead, payroll, taxes, and interest of 2.07 B. Assuming the 90 days trading horizon the next forecasted press release will be in a few days. Check out Betta Pharmaceuticals Basic Forecasting Models to cross-verify your projections.Betta Pharmaceuticals Related Hype Analysis
Having access to credible news sources related to Betta Pharmaceuticals' direct competition is more important than ever and may enhance your ability to predict Betta Pharmaceuticals' future price movements. Getting to know how Betta Pharmaceuticals' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Betta Pharmaceuticals may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| 688520 | Sinocelltech Group | 2.96 | 1 per month | 3.57 | 0.02 | 5.73 | (6.82) | 23.24 | |
| 002065 | Dhc Software Co | (0.57) | 2 per month | 2.98 | 0.20 | 9.97 | (4.46) | 19.97 | |
| 603920 | Olympic Circuit Technology | (0.09) | 2 per month | 4.01 | 0.13 | 9.46 | (7.09) | 19.53 | |
| 000524 | Guangzhou Dongfang Hotel | 0.00 | 0 per month | 2.45 | 0.06 | 3.74 | (2.80) | 19.26 | |
| 002338 | Changchun UP Optotech | 0.71 | 1 per month | 3.02 | 0.16 | 9.72 | (6.63) | 18.30 | |
| 000622 | Hengli Industrial Development | (0.03) | 2 per month | 3.27 | 0.08 | 5.14 | (5.02) | 10.43 | |
| 300805 | Guangdong Brandmax Marketing | 0.26 | 1 per month | 4.23 | 0.13 | 5.20 | (5.17) | 31.32 |
Betta Pharmaceuticals Additional Predictive Modules
Most predictive techniques to examine Betta price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Betta using various technical indicators. When you analyze Betta charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Betta Pharmaceuticals Predictive Indicators
The successful prediction of Betta Pharmaceuticals stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Betta Pharmaceuticals Co, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Betta Pharmaceuticals based on analysis of Betta Pharmaceuticals hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Betta Pharmaceuticals's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Betta Pharmaceuticals's related companies.
Story Coverage note for Betta Pharmaceuticals
The number of cover stories for Betta Pharmaceuticals depends on current market conditions and Betta Pharmaceuticals' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Betta Pharmaceuticals is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Betta Pharmaceuticals' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Other Macroaxis Stories
Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios
Story Categories
Currently Trending Categories
Betta Pharmaceuticals Short Properties
Betta Pharmaceuticals' future price predictability will typically decrease when Betta Pharmaceuticals' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Betta Pharmaceuticals Co often depends not only on the future outlook of the potential Betta Pharmaceuticals' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Betta Pharmaceuticals' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 418.5 M |
Complementary Tools for Betta Stock analysis
When running Betta Pharmaceuticals' price analysis, check to measure Betta Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Betta Pharmaceuticals is operating at the current time. Most of Betta Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Betta Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Betta Pharmaceuticals' price. Additionally, you may evaluate how the addition of Betta Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets |